Concepedia

Erik Slinger

ES

8

Publications

209

Citations

8

H-Index

2013

Active since

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

University of Amsterdam

Erik Slinger is an author at Amsterdam UMC Location University of Amsterdam specializing in tumor microenvironment, medicine, and cancer research.

ORCID

Top concepts

Publications per year

2013–2021

8

Publications

8

Combined ibrutinib and venetoclax treatment vs single agents in the <i>TCL1</i> mouse model of chronic lymphocytic leukemia

Arnon P. Kater, Erik Slinger, Gaspard Cretenet et al. · Blood Advances · 2021 · 36 citations · Full text

Functional disparities among BCL-2 members in tonsillar and leukemic B-cell subsets assessed by BH3-mimetic profiling

Victor Peperzak, Erik Slinger, Johanna ter Burg et al. · Cell Death and Differentiation · 2016 · 31 citations · Full text

, , +17

Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition

Erik Slinger, Rachel Thijssen, Arnon P. Kater et al. · Leukemia · 2017 · 29 citations

, , +12

Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia

Martijn H.A. van Attekum, Sanne Terpstra, Erik Slinger et al. · Oncogene · 2017 · 27 citations · Full text

Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model

Valeria Lascano, Marco Guadagnoli, Jan G. Schot et al. · Blood · 2013 · 25 citations · Full text

Rows per page

1–5 of 8